Navigation Links
Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology
Date:3/15/2010

restore blood flow by opening a clogged vessel and providing support until it is healed. Once the vessel can remain open without the extra support, the bioresorbable scaffold is designed to be slowly metabolized by the body, and is completely dissolved over time. Since a permanent implant is not left behind, a vessel treated with BVS has the ability to ultimately move, flex and pulsate similar to an untreated vessel. The potential to restore these naturally occurring vessel functions, or vascular restoration therapy, is what makes Abbott's BVS unique in the field of cardiology.  

About the ABSORB Clinical Trial

The ABSORB trial is a prospective, non-randomized (open label), two-phase study that enrolled 131 patients from Australia, Belgium, Denmark, France, the Netherlands, New Zealand, Poland and Switzerland. Key endpoints of the study include assessments of safety – MACE and treated site thrombosis rates – at 30 days; six, nine, 12, 18 and 24 months; with additional annual clinical follow-up for up to five years, as well as an assessment of the acute performance of the bioresorbable vascular scaffold, including successful deployment of the system. Other key endpoints of the study include imaging assessments by angiography, intravascular ultrasound (IVUS), optical c
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
5. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
6. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
9. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)...  Following a bipartisan vote in the House ... the Medicare DMEPOS Competitive Bidding Improvement Act of ... released a statement praising the Committee,s work and ... "Today,s mark-up of the Competitive Bidding ... Committee is a critical step forward for this ...
(Date:2/27/2015)... Feb. 27, 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ... both its pro forma net operating loss (NOL) guidance ... strong financial position.  Isis, significantly improved financial results were ... million in payments the Company received from its partners.  ... was a nearly 60% improvement over its 2013 NOL ...
(Date:2/27/2015)... MARLBOROUGH, Mass. , Feb. 27, 2015  Boston ... to participate in the Barclays 2015 Annual Healthcare Conference ... . Dan Brennan , executive vice ... , vice president, Investor Relations, will participate in a ... the host analyst at approximately 1:05 p.m. ET. Following ...
Breaking Medicine Technology:Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2
... 19, 2011 Agendia, an innovative ... published report highlighting the development and validation of ... online in Breast Cancer Research and Treatment ... of Agendia,s Symphony™ suite of breast cancer products, ...
... Sept. 19, 2011 Reportlinker.com announces that ... in its catalogue: South ... to 2017 http://www.reportlinker.com/p0617106/South-and-Central-America-Cardiovascular-Devices-Market-Outlook-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices ... Cardiovascular Devices Market Outlook to 2017 ...
Cached Medicine Technology:Breast Cancer Research and Treatment Highlights Development and Validation of BluePrint® 2Breast Cancer Research and Treatment Highlights Development and Validation of BluePrint® 3South and Central America Cardiovascular Devices Market Outlook to 2017 2South and Central America Cardiovascular Devices Market Outlook to 2017 3South and Central America Cardiovascular Devices Market Outlook to 2017 4South and Central America Cardiovascular Devices Market Outlook to 2017 5South and Central America Cardiovascular Devices Market Outlook to 2017 6South and Central America Cardiovascular Devices Market Outlook to 2017 7South and Central America Cardiovascular Devices Market Outlook to 2017 8South and Central America Cardiovascular Devices Market Outlook to 2017 9South and Central America Cardiovascular Devices Market Outlook to 2017 10South and Central America Cardiovascular Devices Market Outlook to 2017 11South and Central America Cardiovascular Devices Market Outlook to 2017 12South and Central America Cardiovascular Devices Market Outlook to 2017 13South and Central America Cardiovascular Devices Market Outlook to 2017 14South and Central America Cardiovascular Devices Market Outlook to 2017 15South and Central America Cardiovascular Devices Market Outlook to 2017 16South and Central America Cardiovascular Devices Market Outlook to 2017 17
(Date:2/27/2015)... According to court documents, Donna Pirolli was ... 2013 and underwent a procedure during which a duodenoscope ... Because the duodenoscope allegedly had not been properly cleaned, ... Enterobacteriaceae (CRE). , A lawsuit has been ... behalf of Ms. Pirolli alleging that Lutheran General Hospital ...
(Date:2/27/2015)... 2015 Legislation passed today by ... pharmacy provision to help prevent inappropriate prescriptions in ... The Protecting the Integrity of Medicare Act (PIMA), ... Kevin Brady (R-TX) and Ranking Member Jim McDermott ... drug abuse epidemic and implement the right policies, ...
(Date:2/27/2015)... Winter is here, and with it comes harsh snow and ... ice can be harmful on a dog’s paws. Commonly used ... is ready to help pet owners know what to look ... time. , Ice melts can lead to several health hazards ... ice melt products may cause depression, loss of appetite, disorientation, ...
(Date:2/27/2015)... 27, 2015 The Dawn Greene Hospice, a ... Walsh Home (MMW) on the Upper East Side, was officially ... New York, His Eminence Timothy Michael Cardinal Dolan. , Thomas ... of Directors and a member of the ArchCare Board of ... William O’Brien, O.Carm, executive director of MMW, and Christina McInerney, ...
(Date:2/27/2015)... FACE Skincare~Medical~Wellness, a multiaward-winning leader in ... combination to take fifteen years off of an ... new treatment introduced that is the first and ... improve lines and wrinkles on the Décolleté. This ... from the stubborn vertical lines between the upper ...
Breaking Medicine News(10 mins):Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:PCMA Statement on the ‘Protecting the Integrity of Medicare Act’ 2Health News:The Puppy Store Helps Dogs Prepare for Harsh Winter Conditions 2Health News:The Dawn Greene Hospice Is Officially Dedicated 2Health News:The Dawn Greene Hospice Is Officially Dedicated 3Health News:Face Skincare Announces New Combination Therapy 2
... Jan. 12 /PRNewswire-FirstCall/ - SXC Health Solutions Corp. ("SXC" ... SXC), a leading provider of pharmacy benefit management (PBM) ... has been awarded a three-year contract to provide PBM ... Trust (UFCW Trust) based in Walnut Creek, California. The ...
... company expansion into the healthcare IT and government ... 12 Oleen Pinnacle Healthcare Consulting announced today ... (PHS), a Central New York-based IT consulting firm. ... capable of offering healthcare IT services to both ...
... Dr. Jeffrey LaGrasso,( www.LaGrassoMD.com ), Board Certified Plastic ... that he can share the latest medical,techniques, trends ... but with,men and women everywhere. , ... for example, about some of the,less desirable consequences ...
... Medical Equipment the 17th fastest growing business in Louisville, Business First ... , ... (Vocus) January 12, 2009 -- DRE, Inc., a premier international ... of Louisville as a 2008 Company of the Year. The award caps ...
... Hiemstra Product Development, a,premier product design and development ... electronic quality management system (eQMS). , ... development team can reduce,risk and increase speed to ... 13485:2003 and FDA 21 CFR 820 continuously throughout ...
... Committee to Reduce,Infection Deaths (RID) applauds Tom Daschle,s decision to ... Prevention. , Betsy McCaughey, Ph.D., Chairman ... huge problem of hospital infections. We have the science ... have,given the hospitals an excuse to do too little. ...
Cached Medicine News:Health News:SXC Health Solutions selected by UFCW & Employers Benefit Trust to provide PBM services 2Health News:Oleen Pinnacle Announces Acquisition of Partners in Health Systems 2Health News:TransMedia Group Retained by Renowned Plastic Surgeon Dr. Jeffrey Lagrasso to Share Beauty Trends, Warnings and Medical Perspective Previously Limited to the Rich and Famous 2Health News:Business First Selects DRE Medical Equipment as a Company of the Year 2Health News:Business First Selects DRE Medical Equipment as a Company of the Year 3Health News:Reduce Risk, Achieve Compliance and Accelerate Time to Market with hiQual and Hiemstra Product Development 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: